Carole Ho - Insider Trading & Ownership

Location
C/O Denali Therapeutics Inc., 151 Oyster Point Blvd., 2 Nd Floor, South San Francisco, CA
Summary
The estimated net worth of Carole Ho is at least $4.41M dollars as of August 14, 2025. Carole Ho is the Chief Medical Officer of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $3.56M. Carole Ho is the Director of Beam Therapeutics Inc. and owns shares of Beam Therapeutics Inc. (BEAM) stock worth about $564K. Carole Ho is the Director of Royalty Pharma plc and owns shares of Royalty Pharma plc (RPRX) stock worth about $284K.
Signature
/s/ Tyler Nielsen, by power of attorney
All Insider Reports
All Insider Reports

Ownership of Carole Ho

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNLI Denali Therapeutics Inc. Chief Medical Officer $3.56M -$360K -9.18% Aug 12, 2025
BEAM Beam Therapeutics Inc. Director $564K Jun 4, 2025
RPRX Royalty Pharma plc Director $284K Jul 31, 2025
NGM NGM BIOPHARMACEUTICALS INC Director Apr 5, 2024

Insider Transactions Reported by Carole Ho:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.